Creo Medical Group PLC (LON:CREO) Insider Richard John Rees Purchases 4,712 Shares

Creo Medical Group PLC (LON:CREO) insider Richard John Rees purchased 4,712 shares of the stock in a transaction on Thursday, January 16th. The shares were bought at an average cost of GBX 19 ($0.23) per share, for a total transaction of £895.28 ($1,103.92).

Richard John Rees also recently made the following trade(s):

• On Thursday, October 24th, Richard John Rees purchased 98,000 shares of Creo Medical Group stock. The shares were bought at an average cost of GBX 20 ($0.25) per share, for a total transaction of £19,600 ($24,167.69).

Creo Medical Group Stock Down 1.4 %

LON:CREO opened at GBX 18.25 ($0.23) on Tuesday. The firm has a market capitalization of £66.02 million, a price-to-earnings ratio of -304.17 and a beta of 0.86. Creo Medical Group PLC has a twelve month low of GBX 12 ($0.15) and a twelve month high of GBX 43 ($0.53). The stock’s 50 day moving average price is GBX 17.54 and its two-hundred day moving average price is GBX 23.61. The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.